453 related articles for article (PubMed ID: 35897843)
41. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
42. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice.
Feng Z; Pang L; Chen S; Pang X; Huang Y; Qiao Q; Wang Y; Vonglorkham S; Huang Q; Lin X; Wei J
Int Immunopharmacol; 2020 Nov; 88():107003. PubMed ID: 33182043
[TBL] [Abstract][Full Text] [Related]
43. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
[TBL] [Abstract][Full Text] [Related]
44. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic effects of isosteviol sodium on non-alcoholic fatty liver disease by regulating autophagy via Sirt1/AMPK pathway.
Mei Y; Hu H; Deng L; Sun X; Tan W
Sci Rep; 2022 Jul; 12(1):12857. PubMed ID: 35896572
[TBL] [Abstract][Full Text] [Related]
46. γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway.
Liang Y; Zhang Z; Tu J; Wang Z; Gao X; Deng K; El-Samahy MA; You P; Fan Y; Wang F
J Agric Food Chem; 2021 Jul; 69(29):8257-8267. PubMed ID: 34281337
[TBL] [Abstract][Full Text] [Related]
47. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
[TBL] [Abstract][Full Text] [Related]
48. Deletion of Smurf1 attenuates liver steatosis via stabilization of p53.
Lin W; Zhang X; Zhang C; Li L; Zhang J; Xie P; Zhan Y; An W
Lab Invest; 2022 Oct; 102(10):1075-1087. PubMed ID: 35672379
[TBL] [Abstract][Full Text] [Related]
49. Sirt3 activates autophagy to prevent DOX-induced senescence by inactivating PI3K/AKT/mTOR pathway in A549 cells.
Fan X; He Y; Wu G; Chen H; Cheng X; Zhan Y; An C; Chen T; Wang X
Biochim Biophys Acta Mol Cell Res; 2023 Feb; 1870(2):119411. PubMed ID: 36521686
[TBL] [Abstract][Full Text] [Related]
50. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease.
Veskovic M; Mladenovic D; Milenkovic M; Tosic J; Borozan S; Gopcevic K; Labudovic-Borovic M; Dragutinovic V; Vucevic D; Jorgacevic B; Isakovic A; Trajkovic V; Radosavljevic T
Eur J Pharmacol; 2019 Apr; 848():39-48. PubMed ID: 30689995
[TBL] [Abstract][Full Text] [Related]
51. Dietary supplementation of salidroside alleviates liver lipid metabolism disorder and inflammatory response to promote hepatocyte regeneration via PI3K/AKT/Gsk3-β pathway.
Cui Z; Jin N; Amevor FK; Shu G; Du X; Kang X; Ning Z; Deng X; Tian Y; Zhu Q; Wang Y; Li D; Zhang Y; Wang X; Han X; Feng J; Zhao X
Poult Sci; 2022 Sep; 101(9):102034. PubMed ID: 35926351
[TBL] [Abstract][Full Text] [Related]
52. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
[TBL] [Abstract][Full Text] [Related]
53. NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K/Akt/mTOR signaling pathway.
Wang J; Song X; Tan G; Sun P; Guo L; Zhang N; Wang J; Li B
Aging (Albany NY); 2021 Dec; 13(24):25931-25943. PubMed ID: 34928817
[TBL] [Abstract][Full Text] [Related]
54. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Tanaka S; Hikita H; Tatsumi T; Sakamori R; Nozaki Y; Sakane S; Shiode Y; Nakabori T; Saito Y; Hiramatsu N; Tabata K; Kawabata T; Hamasaki M; Eguchi H; Nagano H; Yoshimori T; Takehara T
Hepatology; 2016 Dec; 64(6):1994-2014. PubMed ID: 27637015
[TBL] [Abstract][Full Text] [Related]
55. D-Mannose Regulates Hepatocyte Lipid Metabolism
Hu M; Chen Y; Deng F; Chang B; Luo J; Dong L; Lu X; Zhang Y; Chen Z; Zhou J
Front Immunol; 2022; 13():877650. PubMed ID: 35464439
[TBL] [Abstract][Full Text] [Related]
56. Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1.
Cheng B; Gao W; Wu X; Zheng M; Yu Y; Song C; Miao W; Yang Z; He Y; Liu C; Yang W; Yang X; Li Y; Zhang F; Gao Y
J Agric Food Chem; 2020 Apr; 68(14):4215-4226. PubMed ID: 32181656
[TBL] [Abstract][Full Text] [Related]
57. Medium- and long-chain triglyceride propofol activates PI3K/AKT pathway and inhibits non-alcoholic fatty liver disease by inhibiting lipid accumulation.
Liu H; Hao M; Liu W; Chen H; Han C; Shao Y; Wang L
J Bioenerg Biomembr; 2024 Feb; 56(1):45-53. PubMed ID: 38032443
[TBL] [Abstract][Full Text] [Related]
58. Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.
Ding H; Ge G; Tseng Y; Ma Y; Zhang J; Liu J
Ann Hepatol; 2020; 19(5):516-522. PubMed ID: 32553647
[TBL] [Abstract][Full Text] [Related]
59. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
60. CKIP-1 augments autophagy in steatotic hepatocytes by inhibiting Akt/mTOR signal pathway.
Li L; Xie P; Lin W; Liu J; Chen J; Guo Z; Bin C; An W; Zhang C; Zhan Y
Exp Cell Res; 2020 Dec; 397(1):112341. PubMed ID: 33191205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
